Report Detail

Request for Sample of this report

Pharma & Healthcare Global Blood-derived Products Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4648718
    • |
  • 18 November, 2025
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Blood-derived Products market size was valued at US$ 9646 million in 2024 and is forecast to a readjusted size of USD 14630 million by 2031 with a CAGR of 6.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Blood-derived products, also known as Hemoderivatives, are therapeutic or diagnostic substances obtained from human or animal blood, primarily from plasma. Through industrial-scale fractionation, valuable proteins such as albumin, immunoglobulins, and coagulation factors are isolated for clinical use. These products are essential in treating a variety of conditions, including immune deficiencies, hemophilia, and surgical bleeding. Due to their biological origin, hemoderivatives are subject to strict regulations to ensure viral safety, traceability, and consistent quality. They play a vital role in modern medicine, especially in intensive care, transfusion therapy, and rare disease management.
The Human Bloodm Albumin market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, Human Bloodm Albumin is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.
However, the market faces challenges such as limited plasma supply and high production costs, as Human Bloodm Albumin is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant Human Bloodm Albumin is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global Human Bloodm Albumin market.
The key global producers of Human Bloodm Albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.
This report is a detailed and comprehensive analysis for global Blood-derived Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood-derived Products market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
Global Blood-derived Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
Global Blood-derived Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
Global Blood-derived Products market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood-derived Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood-derived Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood-derived Products market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Albumin
Immunoglobulins
Coagulation Factors
Others
Market segment by Application
Therapeutics
Excipient
Other
Major players covered
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Weiguang Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood-derived Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood-derived Products, with price, sales quantity, revenue, and global market share of Blood-derived Products from 2020 to 2025.
Chapter 3, the Blood-derived Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood-derived Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Blood-derived Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood-derived Products.
Chapter 14 and 15, to describe Blood-derived Products sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Blood-derived Products Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Albumin
    • 1.3.3 Immunoglobulins
    • 1.3.4 Coagulation Factors
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Blood-derived Products Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Therapeutics
    • 1.4.3 Excipient
    • 1.4.4 Other
  • 1.5 Global Blood-derived Products Market Size & Forecast
    • 1.5.1 Global Blood-derived Products Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Blood-derived Products Sales Quantity (2020-2031)
    • 1.5.3 Global Blood-derived Products Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Grifols
    • 2.1.1 Grifols Details
    • 2.1.2 Grifols Major Business
    • 2.1.3 Grifols Blood-derived Products Product and Services
    • 2.1.4 Grifols Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Grifols Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Blood-derived Products Product and Services
    • 2.2.4 CSL Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 Takeda
    • 2.3.1 Takeda Details
    • 2.3.2 Takeda Major Business
    • 2.3.3 Takeda Blood-derived Products Product and Services
    • 2.3.4 Takeda Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Takeda Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Blood-derived Products Product and Services
    • 2.4.4 Octapharma Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 CBPO
    • 2.5.1 CBPO Details
    • 2.5.2 CBPO Major Business
    • 2.5.3 CBPO Blood-derived Products Product and Services
    • 2.5.4 CBPO Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 CBPO Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Blood-derived Products Product and Services
    • 2.6.4 Hualan Bio Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Kedrion
    • 2.7.1 Kedrion Details
    • 2.7.2 Kedrion Major Business
    • 2.7.3 Kedrion Blood-derived Products Product and Services
    • 2.7.4 Kedrion Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Kedrion Recent Developments/Updates
  • 2.8 Shanghai RAAS
    • 2.8.1 Shanghai RAAS Details
    • 2.8.2 Shanghai RAAS Major Business
    • 2.8.3 Shanghai RAAS Blood-derived Products Product and Services
    • 2.8.4 Shanghai RAAS Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Shanghai RAAS Recent Developments/Updates
  • 2.9 LFB Group
    • 2.9.1 LFB Group Details
    • 2.9.2 LFB Group Major Business
    • 2.9.3 LFB Group Blood-derived Products Product and Services
    • 2.9.4 LFB Group Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 LFB Group Recent Developments/Updates
  • 2.10 Weiguang Bio
    • 2.10.1 Weiguang Bio Details
    • 2.10.2 Weiguang Bio Major Business
    • 2.10.3 Weiguang Bio Blood-derived Products Product and Services
    • 2.10.4 Weiguang Bio Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Weiguang Bio Recent Developments/Updates
  • 2.11 Tiantan Bio
    • 2.11.1 Tiantan Bio Details
    • 2.11.2 Tiantan Bio Major Business
    • 2.11.3 Tiantan Bio Blood-derived Products Product and Services
    • 2.11.4 Tiantan Bio Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Tiantan Bio Recent Developments/Updates
  • 2.12 Shuanglin Bio
    • 2.12.1 Shuanglin Bio Details
    • 2.12.2 Shuanglin Bio Major Business
    • 2.12.3 Shuanglin Bio Blood-derived Products Product and Services
    • 2.12.4 Shuanglin Bio Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Shuanglin Bio Recent Developments/Updates
  • 2.13 Boya Bio
    • 2.13.1 Boya Bio Details
    • 2.13.2 Boya Bio Major Business
    • 2.13.3 Boya Bio Blood-derived Products Product and Services
    • 2.13.4 Boya Bio Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Boya Bio Recent Developments/Updates
  • 2.14 Yuanda Shuyang
    • 2.14.1 Yuanda Shuyang Details
    • 2.14.2 Yuanda Shuyang Major Business
    • 2.14.3 Yuanda Shuyang Blood-derived Products Product and Services
    • 2.14.4 Yuanda Shuyang Blood-derived Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Yuanda Shuyang Recent Developments/Updates

3 Competitive Environment: Blood-derived Products by Manufacturer

  • 3.1 Global Blood-derived Products Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Blood-derived Products Revenue by Manufacturer (2020-2025)
  • 3.3 Global Blood-derived Products Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Blood-derived Products by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Blood-derived Products Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Blood-derived Products Manufacturer Market Share in 2024
  • 3.5 Blood-derived Products Market: Overall Company Footprint Analysis
    • 3.5.1 Blood-derived Products Market: Region Footprint
    • 3.5.2 Blood-derived Products Market: Company Product Type Footprint
    • 3.5.3 Blood-derived Products Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Blood-derived Products Market Size by Region
    • 4.1.1 Global Blood-derived Products Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Blood-derived Products Consumption Value by Region (2020-2031)
    • 4.1.3 Global Blood-derived Products Average Price by Region (2020-2031)
  • 4.2 North America Blood-derived Products Consumption Value (2020-2031)
  • 4.3 Europe Blood-derived Products Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Blood-derived Products Consumption Value (2020-2031)
  • 4.5 South America Blood-derived Products Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Blood-derived Products Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Blood-derived Products Sales Quantity by Type (2020-2031)
  • 5.2 Global Blood-derived Products Consumption Value by Type (2020-2031)
  • 5.3 Global Blood-derived Products Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Blood-derived Products Sales Quantity by Application (2020-2031)
  • 6.2 Global Blood-derived Products Consumption Value by Application (2020-2031)
  • 6.3 Global Blood-derived Products Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Blood-derived Products Sales Quantity by Type (2020-2031)
  • 7.2 North America Blood-derived Products Sales Quantity by Application (2020-2031)
  • 7.3 North America Blood-derived Products Market Size by Country
    • 7.3.1 North America Blood-derived Products Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Blood-derived Products Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Blood-derived Products Sales Quantity by Type (2020-2031)
  • 8.2 Europe Blood-derived Products Sales Quantity by Application (2020-2031)
  • 8.3 Europe Blood-derived Products Market Size by Country
    • 8.3.1 Europe Blood-derived Products Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Blood-derived Products Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Blood-derived Products Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Blood-derived Products Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Blood-derived Products Market Size by Region
    • 9.3.1 Asia-Pacific Blood-derived Products Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Blood-derived Products Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Blood-derived Products Sales Quantity by Type (2020-2031)
  • 10.2 South America Blood-derived Products Sales Quantity by Application (2020-2031)
  • 10.3 South America Blood-derived Products Market Size by Country
    • 10.3.1 South America Blood-derived Products Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Blood-derived Products Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Blood-derived Products Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Blood-derived Products Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Blood-derived Products Market Size by Country
    • 11.3.1 Middle East & Africa Blood-derived Products Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Blood-derived Products Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Blood-derived Products Market Drivers
  • 12.2 Blood-derived Products Market Restraints
  • 12.3 Blood-derived Products Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Blood-derived Products and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Blood-derived Products
  • 13.3 Blood-derived Products Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Blood-derived Products Typical Distributors
  • 14.3 Blood-derived Products Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Blood-derived Products. Industry analysis & Market Report on Blood-derived Products is a syndicated market report, published as Global Blood-derived Products Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Blood-derived Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo